NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
August 1, 2006 • Volume 3 / Number 31 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

The information and links on this page are no longer being updated and are provided for reference purposes only.

Notes

John P. Hartinger John P. Hartinger Retires
On July 31, NCI's Associate Director for Budget and Financial Management, John P. Hartinger, retired after more than 40 years of federal service. Mr. Hartinger began his NCI career when its annual budget was slightly more than $230 million compared with today's $4.8 billion. Mr. Hartinger spent most of his time serving as branch chief in the budget office advising several NCI directors, including Drs. Vincent DeVita, Samuel Broder, Richard Klausner, and Andrew von Eschenbach.

NCI Listens and Learns
In an effort to increase the quality and accessibility of cancer information, NCI produced a series of cancer information summaries for patients and health professionals. These peer-reviewed summaries cover topics such as cancer treatment, screening, prevention, genetics, supportive care, and complementary and alternative medicine (CAM). NCI would like the following feedback from the advocacy community and the public on the 14 patient-version cancer information summaries that are related to CAM:
  • Is the type of information provided in the CAM cancer information summaries for patients useful?
  • Is there a CAM therapy for which you would like to see a summary written?
In addition to his many technical and financial skills, which were widely known and admired among those at the National Institutes of Health (NIH), Mr. Hartinger was a role model, mentor, and teacher for many NCI staff members. Earlier this year, former NCI Director Dr. Andrew von Eschenbach established the John P. Hartinger Executive Leadership Development Award, an annual scholarship honoring an NCI employee who demonstrates leadership potential, a commitment to public service, and a desire to further his or her executive development.

Outcomes Assessment in Cancer Trials Conference Announced
NCI will hold a conference, "Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making," September 20-21 in Bethesda, Md., to examine how measurement of patient-reported outcomes, such as symptoms and quality of life, in cancer trials can yield valuable information for decisions about cancer care, third-party reimbursement, and drug approval. The conference will also inform the NCI Clinical Trials Working Group implementation process. For information, contact Dr. Bryce Reeve at reeveb@mail.nih.gov or 301-594-6574.

To learn more about the conference, register, or submit an abstract for a poster presentation, visit http://www.scgcorp.com/PROACT/.

Patient Navigator Training Program Held
Trainees of NCI's Patient Navigator Programs, the American Cancer Society, and the Centers for Medicare and Medicaid Services took part in a 3-day, jointly sponsored training program July 25-27 at the Morehouse School of Medicine in Atlanta. The event focused on information and knowledge sharing, skills building, and the practical application of knowledge and skills learned.

The Patient Navigator Programs, overseen by NCI's Center to Reduce Cancer Health Disparities and established in 2002, consists of three research projects to investigate the effectiveness of patient navigation services. The primary project, Patient Navigator Research Program: Eliminating Barriers to Timely Delivery of Cancer Diagnosis and Treatment Services, is providing 5-year funding to eight institutions to develop and assess the efficacy and cost-effectiveness of various innovative navigator interventions in communities experiencing cancer health disparities.

Immunology Conference Slated for September
NCI's Center for Cancer Research will host "Frontiers in Basic Immunology," a national symposium featuring leaders in the field of immunologic mechanisms. The conference will take place September 28-29 on the NIH campus in Bethesda, Md., and feature sessions on signaling and effector cell function, lymphoid development and differentiation, and cellular and innate immunity.

There is no charge for the symposium, but registration is required. Seating is limited, so early registration is encouraged at http://web.ncifcrf.gov/events/basicimmunology/default.asp. For additional information, contact Karen Kochersberger at kkochersberger@ncifcrf.gov or 301-228-4027.